Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: The Women's Health Initiative hormone therapy clinical trials

Marianne Canonico, Geneviève Plu-Bureau, Mary Jo O'Sullivan, Marcia L. Stefanick, Barbara Cochrane, Pierre Yves Scarabin, Joann E. Manson

Research output: Contribution to journalArticle

27 Scopus citations

Abstract

OBJECTIVE: This study aims to investigate venous thromboembolism (VTE) risk in relation to age at menopause, age at menarche, parity, bilateral oophorectomy, and time since menopause, as well as any interaction with randomized hormone therapy (HT) assignment, among postmenopausal women. METHODS: Using pooled data from the Women's Health Initiative HT clinical trials including 27,035 postmenopausal women aged 50 to 79 years who had no history of VTE, we assessed the risk of VTE in relation to age at menopause, age at menarche, parity, bilateral oophorectomy, and time since menopause by Cox proportional hazards models. Linear trends, quadratic relationships, and interactions of reproductive life characteristics with HT on VTE risk were systematically tested. RESULTS: During follow-up, 426 women reported a first VTE, including 294 non-procedure-related events. No apparent interaction of reproductive life characteristics with HT assignment on VTE risk was detected, and there was not a significant association between VTE and age at menarche, age at menopause, parity, oophorectomy, or time since menopause. However, analyses restricted to non-procedure-related VTE showed a U-shaped relationship between age at menopause and thrombotic risk that persisted after multivariable analysis (P < 0.01). Compared with women aged 40 to 49 years at menopause, those who had early menopause (age <40 y) or late menopause (age >55 y) had a significantly increased VTE risk (hazard ratio [95% CI]: 1.8 [1.2-2.7] and 1.5 [1.0-2.4], respectively). CONCLUSIONS: Reproductive life characteristics have little association with VTE and do not seem to influence the effect of HT on thrombotic risk among postmenopausal women. Nevertheless, early and late onset of menopause might be newly identified risk factors for non-procedure-related VTE.

Original languageEnglish (US)
Pages (from-to)214-220
Number of pages7
JournalMenopause
Volume21
Issue number3
DOIs
StatePublished - Mar 1 2014

Keywords

  • Age at menopause
  • Risk factors
  • Venous thromboembolism

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: The Women's Health Initiative hormone therapy clinical trials'. Together they form a unique fingerprint.

  • Cite this